SCHEMBL7569609

SCHEMBL7569609

c1cncc(CCc2nncc3ccccc23)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
GPR84 Q9NQS5 1/20 0.46
CHRNA7 P36544 2/20 0.45
CYP19A1 P11511 1/20 0.44
CYP2A6 P11509 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HRH1 P35367 2/20 0.41
GBA1 P04062 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
FDPS P14324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29981747 1.00 CYP1A2 (0.46) CYP1A2CYP2D6GPR84CHRNA7CYP19A1
SCHEMBL9807642 0.86 CYP19A1 (0.54) CYP1A2CYP2D6CYP19A1HRH4HRH3
SCHEMBL4814640 0.76 FLT1 (0.48) CYP1A2CYP2D6GPR84CHRNA7CYP2A6
SCHEMBL7074857 0.74 MPO (0.44) CYP1A2CYP2D6CYP19A1TDP1KDM4E
SCHEMBL7551411 0.74 LMNA (0.42) CYP1A2CYP2D6CYP19A1TDP1KDM4E
SCHEMBL5270596 0.74 EGFR (0.46) CYP1A2CYP2D6CYP19A1TDP1KDM4E
SCHEMBL29485692 0.74 CHRNA7 (0.74) CYP1A2CYP2D6CHRNA7CYP2A6HRH4
SCHEMBL724866 0.74 CHRNA7 (0.74) CYP1A2CYP2D6CHRNA7CYP2A6HRH4
SCHEMBL31738482 0.74 CYP19A1 (0.61) CYP1A2CYP2D6CYP19A1TDP1KDM4E
SCHEMBL7069713 0.74 CYP19A1 (0.61) CYP1A2CYP2D6CYP19A1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165085-A1 PHTHALAZINE DERIVATIVES FOR TREATING INFLAMMATORY DISEASES Novartis AG (CH) 2002-01-02 EP disclosed
WO-2000059509-A1 PHTHALAZINE DERIVATIVES FOR TREATING INFLAMMATORY DISEASES NOVARTIS AG (CH) 2000-10-12 WO disclosed